Bilimsel çalışmalar

Prof. Dr. Yusuf Karakaş

50 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Clinical Breast Cancer, 2025

    DOI 10.1016/j.clbc.2025.03.003 PMID 40190010 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  2. HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1639022 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  3. Ostracism in Adolescent Cancer Patients and Predictors (OSTRACA Study): A Pilot Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 2025

    DOI 10.47572/muskutd.1503098 Kaynak: OpenAlex

  4. Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-56046-w PMID 38461209 16 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  5. Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study

    BMC Cancer, 2024

    DOI 10.1186/s12885-024-13357-5 PMID 39736618 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  6. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  7. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1287 PMID 37133230 22 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

    Journal of Chemotherapy, 2022

    DOI 10.1080/1120009x.2022.2073159 PMID 35579894 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  9. Gastrointestinal Sistem Tümörleri-1

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1211 Açık erişimli tam metinKaynak: OpenAlex

  10. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience

    South Asian Journal of Cancer, 2022

    DOI 10.1055/s-0042-1755467 PMID 36756104 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  11. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study

    Journal of Cancer Research and Clinical Oncology, 2021

    DOI 10.1007/s00432-021-03748-7 PMID 34331582 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  12. Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)

    Indian Journal of Hematology and Blood Transfusion, 2020

    DOI 10.1007/s12288-020-01257-0 PMID 33100705 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  13. Worse patient–physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    European Journal of Cancer Care, 2020

    DOI 10.1111/ecc.13296 PMID 32864838 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  14. Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

    Journal of Hepatocellular Carcinoma, 2020

    DOI 10.2147/jhc.s258930 PMID 32984091 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  15. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience

    The Turkish Journal of Gastroenterology, 2020

    DOI 10.5152/tjg.2020.18919 PMID 32141816 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  16. Multimodality Treatment in Malignant Peripheral Nerve Sheath Tumors

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2019-73127 Kaynak: OpenAlex

  17. COVID-19 Pandemisinde Gastrointestinal Kanserlere Yaklaşım

    Türkiye Klinikleri COVID - 19, 2020

    Kaynak: OpenAlex

  18. Analysis of FUSOBACTERIUM NUCLEATUM and Streptococcus Gallolyticus in Saliva of Colorectal Cancer Patients

    Biomarkers in Medicine, 2019

    DOI 10.2217/bmm-2019-0020 PMID 31157977 34 atıf (Europe PMC) Kaynak: OpenAlex

  19. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study

    Archives of Medical Science, 2019

    DOI 10.5114/aoms.2019.83000 PMID 34336021 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  20. Is microsatellite instability a negative prognostic factor in early stage endometrial cancer patients?

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.15_suppl.e17107 Kaynak: OpenAlex

  21. Worse patient- physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Oncology Group (TOG)

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz262.001 Açık erişimli tam metinKaynak: OpenAlex

  22. Hakkari İlinde Görülen Kanser Türlerinin ve Prevalanslarının Değerlendirilmesi

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2019

    DOI 10.31067/0.2019.235 Kaynak: OpenAlex

  23. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma

    Current Problems in Cancer, 2018

    DOI 10.1016/j.currproblcancer.2018.01.011 PMID 29576383 10 atıf (Europe PMC) Kaynak: OpenAlex

  24. The role of ABO blood groups in glial neoplasms

    British Journal of Neurosurgery, 2018

    DOI 10.1080/02688697.2018.1522415 PMID 30394124 3 atıf (Europe PMC) Kaynak: OpenAlex

  25. Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey

    The Turkish Journal of Gastroenterology, 2018

    DOI 10.5152/tjg.2018.17660 PMID 30249555 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  26. When side effect becomes the effect: Efficacy of capecitabine in refractory psoriasis

    Dermatologic Therapy, 2018

    DOI 10.1111/dth.12629 PMID 30230162 Açık erişimli tam metinKaynak: OpenAlex

  27. Analysis of Fusobacterium nucleatum, Streptococcus gallolyticus and Porphyromonas gingivalis in saliva in colorectal cancer patients and healthy controls.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e15617 5 atıf (OpenAlex) Kaynak: OpenAlex

  28. Ostracism in adolescent cancer patients and predictors (OSTRACA Study): A study of the palliative care working committee of the Turkish Oncology Group (TOG)

    Annals of Oncology, 2018

    DOI 10.1093/annonc/mdy296.004 Kaynak: OpenAlex

  29. Marjinal Zon Lenfomalarının Demografik ve Klinik Özellikleri:Türk Onkoloji Grubu Retrospektif Çalışması

    Van Yüzüncü Yıl University Academic Data Management System, 2017

    Kaynak: OpenAlex

  30. Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient

    Oncology Research and Treatment, 2017

    DOI 10.1159/000477968 PMID 28950270 24 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  31. Recent advances in the management of pancreatic adenocarcinoma

    Expert Review of Anticancer Therapy, 2017

    DOI 10.1080/14737140.2018.1403319 PMID 29125367 18 atıf (Europe PMC) Kaynak: OpenAlex

  32. The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival

    Clinical Breast Cancer, 2017

    DOI 10.1016/j.clbc.2017.11.002 PMID 29183716 9 atıf (Europe PMC) Kaynak: OpenAlex

  33. Tumor Sidedness and Prognosis in Colorectal Cancer

    JAMA Oncology, 2017

    DOI 10.1001/jamaoncol.2017.0034 PMID 28418502 8 atıf (Europe PMC) Kaynak: OpenAlex

  34. Kaposi’s Sarcoma Epidemiology, Risk Factors, Staging and Treatment: AN OVERVIEW.

    Acta Oncologica Turcica, 2017

    DOI 10.5505/aot.2017.59023 Kaynak: OpenAlex

  35. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers.

    PubMed, 2017

    PMID 28730766 4 atıf (Europe PMC) Kaynak: OpenAlex

  36. Oncologists’ Perspectives on Consolidation Radiation Treatment after Chemotherapy for Lymphomas: A Survey Study by the Lymphoma Working Committee of the Turkish Oncology Group (TOG)

    Europe PMC (PubMed Central), 2017

    DOI 10.22034/apjcp.2017.18.11.3149 PMID 29172293 Açık erişimli tam metinKaynak: OpenAlex

  37. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience.

    PubMed, 2016

    PMID 27685902 1 atıf (Europe PMC) Kaynak: OpenAlex

  38. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.

    PubMed, 2016

    PMID 27273947 8 atıf (Europe PMC) Kaynak: OpenAlex

  39. A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer

    OncoTargets and Therapy, 2016

    DOI 10.2147/ott.s95020 PMID 27536145 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  40. Tendency of cancer patients and their relatives to use internet for health-related searches: Turkish Oncology Group (TOG) Study.

    PubMed, 2016

    PMID 27569068 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  41. Vaccination perception and attitudes among patients with cancer receiving chemotherapy

    Annals of Oncology, 2016

    DOI 10.1093/annonc/mdw390.52 Kaynak: OpenAlex

  42. Analysis of the Adjuvant Hormone Therapy Randomized Trial

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2015.65.4277 PMID 27001585 1 atıf (Europe PMC) Kaynak: OpenAlex

  43. The impact of the total size of lesions in multifocal/multicentric breast cancer on survival.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e12030 Kaynak: OpenAlex

  44. Chemotherapy might not be beneficial in lymph node- negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis.

    PubMed, 2015

    PMID 26011339 2 atıf (Europe PMC) Kaynak: OpenAlex

  45. Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e11549 Kaynak: OpenAlex

  46. Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen

    OncoTargets and Therapy, 2015

    DOI 10.2147/ott.s82906 PMID 25999738 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  47. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12036 8 atıf (OpenAlex) Kaynak: OpenAlex

  48. A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature.

    PubMed, 2015

    PMID 25778338 Kaynak: OpenAlex

  49. Neuroendocrine breast cancer: A single center experience.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12037 Kaynak: OpenAlex

  50. Analysis of the Adjuvant Hormone Therapy Randomized Tria

    Kaynak: acibadem.com.tr profil sayfası